Probasin promoter-driven expression of ID1 is not sufficient for carcinogenesis in rodent prostate

Robert Salomon, Lei Young, Duncan MacLeod, Xiao-Ling Yu, Qihan Dong

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)

    Abstract

    Inhibitor of DNA-binding-1 (ID1) negatively regulates cell differentiation and senescence, and enhances cellular proliferation and angiogenesis. Elevated levels of ID1 have been found in a variety of cancers, including prostate cancer, but whether ID1 has a tumourigenic role remains to be established. We established heterozygous and homozygous ID1-transgenic mouse lines driven by the prostate-specific probasin promoter ( - 426 to +28 bp). Although elevated levels of ID1 were confirmed by RT-PCR, immunohistochemistry, and Western blot analysis, there were no morphological changes identified in the prostate of transgenic mice at 26 and 52 weeks. Thus, overexpression of ID1 alone is not sufficient to drive neoplastic change in mouse prostate.
    Original languageEnglish
    Pages (from-to)599-604
    Number of pages6
    JournalJournal of Histochemistry and Cytochemistry
    Volume57
    Issue number6
    DOIs
    Publication statusPublished - 2009

    Fingerprint

    Dive into the research topics of 'Probasin promoter-driven expression of ID1 is not sufficient for carcinogenesis in rodent prostate'. Together they form a unique fingerprint.

    Cite this